Debut of the world’s first metaverse browser in June now opens development to everyone Six months after unveiling the world’s first metaverse browser at AWE 2025, RP1 is officially opening access on ...
COLUMBUS, Ohio, December 04, 2025--(BUSINESS WIRE)--Six months after unveiling the world’s first metaverse browser at AWE 2025, RP1 is officially opening access on December 8, 2025 for developers ...
DayZ and Kerbal Space Program's creators have joined forces with an ex-SpaceX engineer to create the ultimate spaceflight simulator. When you purchase through links on our site, we may earn an ...
You note that the rejection of Replimune’s metastatic-melanoma immunotherapy, RP1, harms patients and stunts pharmaceutical development (“The Spin Doctors at the FDA,” Review & Outlook, Oct. 28) It ...
After Ontario releases an ad featuring Ronald Reagan touting free trade over tariffs, Donald Trump increases the tariffs on Canada to 10% in response. Is Trump right about Reagan? Plus, President ...
The biotech received the good news it was hoping for from a top national regulator. This concerned RP1, its advanced melanoma drug. Well before market open, Replimune announced that the U.S. Food and ...
Shares of Replimune Group, Inc. (NASDAQ:REPL) are rising Monday after the clinical stage biotechnology company shared an important regulatory update. What To Know: Replimune said the U.S. Food and ...
Hosted on MSN
Replimune Group’s FDA Resubmission for RP1 Accepted
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. An update from Replimune Group ( (REPL)) ...
NASA on Monday introduced 10 new astronauts, four men and six women selected from more than 8,000 applicants, to begin training for future flights to the International Space Station, the moon and, ...
The last time I spoke about Replimune (REPL) it was with respect to a Seeking Alpha article entitled "Replimune: Scope Goes Beyond That of RP1 Oncolytic Targeting For Melanoma." With respect to this ...
The fate of a once-promising cancer treatment now looks uncertain at best. The meeting was conducted with U.S. Food and Drug Administration (FDA) officials, and it took place on Tuesday. The subject ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback